A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.

Last year, a puzzling case caught the attention of Dr. Mary Lee-Wong at Maimonides Medical Center. An elderly patient with both asthma and chronic obstructive pulmonary disease had shown no signs of ...